Jason John Luke

Jason John Luke

University of Pittsburgh - Pittsburgh / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4702375
person_outline Jason John Luke's MOST POPULAR ARTICLES
1-) The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patientsV Matson, J Fessler, R Bao, T Chongsuwat, Y Zha, ML Alegre, JJ Luke, ...Science 359 (6371), 104-108, 201817802018
2-) Targeted agents and immunotherapies: optimizing outcomes in melanomaJJ Luke, KT Flaherty, A Ribas, GV LongNature reviews Clinical oncology 14 (8), 463-482, 20179562017
3-) Safety and efficacy of durvalumab (MEDI4736), an anti–programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancerC Massard, MS Gordon, S Sharma, S Rafii, ZA Wainberg, J Luke, ...Journal of Clinical Oncology 34 (26), 3119, 20167952016
4-) Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNAGR Oxnard, CP Paweletz, Y Kuang, SL Mach, A O\'Connell, MM Messineo, ...Clinical cancer research 20 (6), 1698-1705, 20148672014
5-) Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinFS Hodi, CL Corless, A Giobbie-Hurder, JA Fletcher, M Zhu, ...Journal of clinical oncology 31 (26), 3182-3190, 20137022013